March 8, 2024: Camp Lejeune Update
Advancing Track 2 Discovery in Litigation On March 8, 2024, during a pivotal moment in the ongoing litigation, plaintiffs’ lawyers advocated for progress in Track 2 cases, which encompass a range of serious illnesses including prostate cancer, liver cancer, lung cancer, breast cancer, and kidney disease. They urged the court to lift the stay on…